Hydroxysafflor yellow A suppresses liver fibrosis induced by carbon tetrachloride with high-fat diet by regulating PPAR-γ/p38 MAPK signaling

References

• Awad MM, Enslen H, Boylan JM, et al. (2000). Growth regulation via p38 mitogen-activated protein kinase in developing liver. J Biol Chem 275:38716–21
   PubMed Web of Science ®Google Scholar
• Canbay A, Feldstein AE, Higuchi H, et al. (2003). Kupffer cell engulfment of apoptotic bodies stimulates death ligand and cytokine expression. Hepatology 38:1188–98
   PubMed Web of Science ®Google Scholar
• Cheung KF, Ye DW, Yang ZF, et al. (2009). Therapeutic efficacy of traditional Chinese medicine 319 recipe on hepatic fibrosis induced by carbon tetrachloride in rats. J Ethnopharmacol 124:142–50
   Google Scholar
• Comporti M, Signorini C, Arezzini B, et al. (2008). Isoprostanes and hepatic fibrosis. Mol Aspects Med 29:43–9
   PubMed Web of Science ®Google Scholar
• Domitrovi R, Jakovac H, Blagojevi G. (2011). Hepatoprotective activity of berberine is mediated by inhibition of TNF-alpha, COX-2, and iNOS expression in CCl(4)-intoxicated mice. Toxicology 280:33–43
   Google Scholar
• Friedman SL. (2003). Liver fibrosis-from bench to bedside. J Hepatol 38:S38–53
   PubMed Web of Science ®Google Scholar
• Goldstein DM, Kuglstatter A, Lou Y, Soth MJ. (2010). Selective p38alpha inhibitors clinically evaluated for the treatment of chronic inflammatory disorders. J Med Chem 53:2345–53
   PubMed Web of Science ®Google Scholar
• Hayasaka A, Saisho H. (1998). Serum markers as tools to monitor liver fibrosis. Digestion 59:381–4
   PubMedGoogle Scholar
• He H, Yang X, Shi M, et al. (2008). Protective effects of hydroxysafflor yellow A on acute and chronic congestive cardiac failure mediated by reducing ET-1, NOS and oxidative stress in rats. J Pharm Pharmacol 60:115–23
   PubMed Web of Science ®Google Scholar
• Iimuro Y, Brenner DA. (2008). Matrix metalloproteinase gene delivery for liver fibrosis. Pharm Res 25:249–58
   PubMed Web of Science ®Google Scholar
• Inagaki Y, Okazaki I. (2007). Emerging insights into transforming growth factor beta Smad signal in hepatic fibrogenesis. Gut 56:284–92
   PubMed Web of Science ®Google Scholar
• Ishihara K, Miyazaki A, Nabe T, et al. (2012). Group IVA phospholipase A2 participates in the progression of hepatic fibrosis. FASEB J 26:4111–21
   PubMed Web of Science ®Google Scholar
• Kohli R, Kirby M, Xanthakos SA, et al. (2010). High-fructose, medium chain trans fat diet induces liver fibrosis and elevates plasma coenzyme Q9 in a novel murine model of obesity and nonalcoholic steatohepatitis. Hepatology 52:934–44
   PubMed Web of Science ®Google Scholar
• Kohli R, Kirby M, Xanthakos SA, et al. (2013). A high-fat diet and multiple administration of carbon tetrachloride induces liver injury and pathological features associated with non-alcoholic steatohepatitis in mice. Clin Exp Pharmacol Physiol 40:422–30
   Google Scholar
• Lee CH, Olson P, Evans RM. (2003). Minireview: Lipid metabolism, metabolic diseases, and peroxisome proliferator-activated receptors. Endocrinology 144:2201–7
   PubMed Web of Science ®Google Scholar
• Lee TF, Lin YL, Huang YT. (2012). Protective effects of kaerophyllin against liver fibrogenesis in rats. Eur J Clin Invest 42:607–16
   PubMed Web of Science ®Google Scholar
• Lewindon PJ, Pereira TN, Hoskins AC, et al. (2002). The role of hepatic stellate cells and transforming growth factor-beta(1) in cystic fibrosis liver disease. Am J Pathol 160:1705–15
   Google Scholar
• Li CC, Yang CZ, Li XM, et al. (2012). Hydroxysafflor yellow A induces apoptosis in activated hepatic stellate cells through ERK1/2 pathway in vitro. Eur J Pharm Sci 46:397–404
   Google Scholar
• Li X, Wang X, Han C, et al. (2013). Astragaloside IV suppresses collagen production of activated hepatic stellate cells via oxidative stress-mediated p38 MAPK pathway. Free Radic Biol Med 60:168–76
   PubMed Web of Science ®Google Scholar
• Lin X, Zhang S, Huang Q, et al. (2012). Protective effect of Fufang–Liu–Yue–Qing, a traditional Chinese herbal formula, on CCl4 induced liver fibrosis in rats. J Ethnopharmacol 142:548–56
   PubMed Web of Science ®Google Scholar
• Miyahara T, Schrum L, Rippe R, et al. (2000). Peroxisome proliferator-activated receptors and hepatic stellate cell activation. J Biol Chem 275:35715–22
   PubMed Web of Science ®Google Scholar
• Murawaki Y, Ikuta Y, Koda M, et al. (1996). Clinical significance of serum hyaluronan in patients with chronic viral liver disease. J Gastroenterol Hepatol 11:459–65
   Google Scholar
• Peng Y, Yang H, Zhu T, et al. (2013). The antihepatic fibrotic effects of fluorofenidone via MAPK signalling pathways. Eur J Clin Invest 43:358–68
   PubMed Web of Science ®Google Scholar
• Povero D, Busletta C, Novo E, et al. (2010). Liver fibrosis: A dynamic and potentially reversible process. Histol Histopathol 25:1075–91
   PubMedGoogle Scholar
• Sakaida I, Hironaka K, Kimura T, et al. (2004). Herbal medicine Sho-saiko-to(TJ-9) increases expression matrix metalloproteinases (MMPs) with reduced expression of tissue inhibitor of metalloproteinases (TIMPs) in rat stellate cell medicine Sho-saiko-to(TJ-9) increases expression matrix metalloproteinases (MMPs) with reduced expression of tissue inhibitor of metalloproteinases (TIMPs) in rat stellate cell. Life Sci 74:2251–63
   Google Scholar
• Seth RK, Kumar A, Das S, et al. (2013). Environmental toxin-linked nonalcoholic steatohepatitis and hepatic metabolic reprogramming in obese mice. Toxicol Sci 134:291–303
   Google Scholar
• She H, Xiong S, Hazra S, Tsukamoto H. (2005). Adipogenic transcriptional regulation of hepatic stellate cells. J Biol Chem 280:4959–67
   PubMed Web of Science ®Google Scholar
• Sinha-Hikim I, Sinha-Hikim AP, Shen R, et al. (2011). A novel cystine based antioxidant attenuates oxidative stress and hepatic steatosis in diet-induced obese mice. Exp Mol Pathol 91:419–28
   Google Scholar
• Song L, Zhu Y, Jin M, Zang B. (2013). Hydroxysafflor yellow A inhibits lipopolysaccharide-induced inflammatory signal transduction in human alveolar epithelial A549 cells. Fitoterapia 84:107–14
   PubMed Web of Science ®Google Scholar
• Sun CY, Pei CQ, Zang BX, et al. (2010). The ability of hydroxysafflor yellow A to attenuate lipopolysaccharide-induced pulmonary inflammatory injury in mice. Phytother Res 24:1788–95
   Google Scholar
• Sun L, Yang L, Xu YW, et al. (2012). Neuroprotection of hydroxysafflor yellow A in the transient focal ischemia: Inhibition of protein oxidation/nitration, 12/15-lipoxygenase and blood-brain barrier disruption. Brain Res 1473:227–35
   PubMed Web of Science ®Google Scholar
• Tien YC, Lin JY, Lai CH, et al. (2010). Carthamus tinctorius L. prevents LPS-induced TNFalpha signaling activation and cell apoptosis through JNK1/2-NFkappaB pathway inhibition in H9c2 cardiomyoblast cells. J Ethnopharmacol 130:505–13
   PubMedGoogle Scholar
• Trebicka J, Hennenberg M, Odenthal M, et al. (2010). Atorvastatin attenuates hepatic fibrosis in rats after bile duct ligation via decreased turnover of hepatic stellate cells. J Hepatol 53:702–12
   PubMed Web of Science ®Google Scholar
• Wang CY, Liu Q, Huang QX, et al. (2013). Activation of PPAR-γ is required for hydroxysafflor yellow A of Carthamus tinctorius to attenuate hepatic fibrosis induced by oxidative stress. Phytomedicine 20:592–9
   PubMed Web of Science ®Google Scholar
• Wang JH, Shin JW, Son JY, et al. (2010). Antifibrotic effects of CGX, a traditional herbal formula, and its mechanisms in rats. J Ethnopharmacol 127:534–42
   PubMedGoogle Scholar
• Xiao J, Ho CT, Liong EC, et al. (2013). Epigallocatechin gallate attenuates fibrosis, oxidative stress, and inflammation in non-alcoholic fatty liver disease rat model through TGF/SMAD, PI3 K/Akt/FoxO1, and NF-kappa B pathways. Eur J Nutr [Online]. Available from: http://dx.doi.org/10.1007/s00394-013-0516-8 [last accessed 21 Mar 2013]
   Google Scholar
• Yan Z, Ni Y, Wang P, et al. (2013). Peroxisome proliferator-activated receptor delta protects against obesity-related glomerulopathy through the P38MAPK pathway. Obesity (Sliver Spring) 21:538–45
   Google Scholar
• Yang L, Chan CC, Kwon OS, et al. (2006). Regulation of peroxisome proliferator-activated receptor-gamma in liver fibrosis. Am J Physiol Gastrointest Liver Physiol 291:G902–11
   PubMed Web of Science ®Google Scholar
• Yang Y, Yang S, Chen M, et al. (2008). Compound Astragalus and Salvia miltiorrhiza extract exerts anti-fibrosis by mediating TGF-beta/Smad signaling in myofibroblasts. J Ethnopharmacol 118:264–70
   Google Scholar
• Yu J, Wang Y, Qian H, et al. (2012). Polyprenols from Taxus chinensis var. mairei prevent the development of CCl4-induced liver fibrosis in rats. J Ethnopharmacol 142:151–60
   PubMed Web of Science ®Google Scholar
• Zeng XX, Bian ZX, Wu TX, et al. (2011). Traditional Chinese medicine syndrome distribution in chronic hepatitis B populations: A systematic review. Am J Chin Med 39:1061–74
   PubMed Web of Science ®Google Scholar
• Zhang Y, Guo J, Dong H, et al. (2011). Hydroxysafflor yellow A protects against chronic carbon tetrachloride-induced liver fibrosis. Eur J Pharmacol 660:438–44
   PubMed Web of Science ®Google Scholar
• Zhou Y, Jia X, Qin J, et al. (2010). Leptin inhibits PPARgamma gene expression in hepatic stellate cells in the mouse model of liver damage. Mol Cell Endocrinol 323:193–200
   Google Scholar